We are live on ! Find out more
SGL

Sonic GP LLC Portfolio holdings

AUM $45.4M
1-Year Est. Return 5.08%
This Fund
S&P 500
This Quarter Est. Return
+6.16%
1 Year Est. Return
+5.08%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$150M
AUM Growth
+$18.9M
Cap. Flow
+$13M
Cap. Flow %
8.69%
Top 10 Hldgs %
76.09%
Holding
26
New
1
Increased
2
Reduced
Closed
2

Top Buys

Rank Stock Value
1
MANU icon
Manchester United
MANU
+$15.5M
2
RGNX icon
Regenxbio
RGNX
+$10.6M
3
SPNT icon
SiriusPoint
SPNT
+$914K

Top Sells

Rank Stock Value
1
USFD icon
US Foods
USFD
+$7.39M
2
RDN icon
Radian Group
RDN
+$6.63M

Sector Composition

Rank Sector Weight
1 Healthcare 26.61%
2 Financials 16.37%
3 Industrials 15.32%
4 Materials 12.21%
5 Communication Services 12.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USFD icon
26
US Foods
USFD
$23.7B
-200,000
Closed -$7.39M

Similar funds

Sonic GP LLC's Q2 2023 Portfolio in Review

As of Q2 2023, Sonic GP LLC held 26 positions worth $150M, up 14% from $131M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Sonic GP LLC deployed $13M of net new capital in Q2 2023, opening 1 new position and adding to 2 existing holdings. Its largest new stake was Manchester United: 750,000 shares worth $18.3M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.

On the sell side, the most notable exit was US Foods, an estimated $7.39M sold.

  • Sonic GP LLC's largest Q2 2023 buy was Manchester United: 750,000 shares worth $18.3M.
  • Sonic GP LLC added most to Regenxbio in Q2 2023, an estimated $10.6M increase.
  • Sonic GP LLC fully exited US Foods in Q2 2023, selling an estimated $7.39M.
  • Sonic GP LLC's ten largest holdings make up 76% of its $150M portfolio in Q2 2023.
  • Sonic GP LLC opened 1 new position and closed 2 in Q2 2023.
  • Sonic GP LLC's portfolio value rose 14% quarter-over-quarter to $150M.

Based on Sonic GP LLC's 13F filing for Q2 2023, filed 14 Aug 2023.